{
    "Trade/Device Name(s)": [
        "ADVIA Centaur\u00ae Vitamin D Total (VitD)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K200509",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133156"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "May 29, 2020",
    "Summary Letter Received Date": "March 2, 2020",
    "Submission Date": "February 28, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Total 25(OH)vitamin D"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "Gel-barrier tube (serum)"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur\u00ae system"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Chemiluminescence"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Diluent",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Vitamin D Total (VitD) assay for the quantitative determination of total 25(OH)vitamin D in serum and plasma using chemiluminescent immunoassay.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of total 25(OH)vitamin D in human serum and plasma as an aid in the determination of vitamin D sufficiency.",
    "fda_folder": "Clinical Chemistry"
}